{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:27:36Z","timestamp":1760549256578},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s7960","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T15:52:24Z","timestamp":1342194744000},"page":"181","source":"Crossref","is-referenced-by-count":9,"title":["Temsirolimus in the treatment of relapsed and\/or refractory mantle cell lymphoma"],"prefix":"10.2147","author":[{"given":"Sara","family":"Galimberti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,6]]},"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=6615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:04:11Z","timestamp":1477850651000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/temsirolimus-in-the-treatment-of-relapsed-andor-refractory-mantle-cell-peer-reviewed-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/cmar.s7960","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}